Business Description
Bioinfra Co Ltd
ISIN : KR7199730003
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.39 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | 5.12 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.05 | |||||
Beneish M-Score | -2.06 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -23.4 | |||||
3-Year EBITDA Growth Rate | -36.3 | |||||
3-Year EPS without NRI Growth Rate | -47.1 | |||||
3-Year Book Growth Rate | 31.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.91 | |||||
9-Day RSI | 56.37 | |||||
14-Day RSI | 55.77 | |||||
6-1 Month Momentum % | -24.73 | |||||
12-1 Month Momentum % | -39.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.67 | |||||
Quick Ratio | 1.67 | |||||
Cash Ratio | 1.14 | |||||
Days Sales Outstanding | 39.82 | |||||
Days Payable | 28.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 6.61 | |||||
Forward Dividend Yield % | 6.61 | |||||
5-Year Yield-on-Cost % | 6.61 | |||||
3-Year Average Share Buyback Ratio | -51.6 | |||||
Shareholder Yield % | 4.96 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 28.37 | |||||
Operating Margin % | -6.64 | |||||
Net Margin % | -2.92 | |||||
FCF Margin % | -15.92 | |||||
ROE % | -2.45 | |||||
ROA % | -1.68 | |||||
ROIC % | -2.36 | |||||
3-Year ROIIC % | -16.96 | |||||
ROC (Joel Greenblatt) % | -6.66 | |||||
ROCE % | -3.52 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.59 | |||||
PB Ratio | 1.49 | |||||
Price-to-Tangible-Book | 1.54 | |||||
Price-to-Operating-Cash-Flow | 94.02 | |||||
EV-to-EBIT | -31.43 | |||||
EV-to-EBITDA | 24.76 | |||||
EV-to-Revenue | 1.5 | |||||
EV-to-FCF | -10.93 | |||||
Price-to-Net-Current-Asset-Value | 19.66 | |||||
Earnings Yield (Greenblatt) % | -3.18 | |||||
FCF Yield % | -9.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bioinfra Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 26,356.605 | ||
EPS (TTM) (â‚©) | -149 | ||
Beta | 0 | ||
Volatility % | 29.16 | ||
14-Day RSI | 55.77 | ||
14-Day ATR (â‚©) | 551.791668 | ||
20-Day SMA (â‚©) | 8244 | ||
12-1 Month Momentum % | -39.57 | ||
52-Week Range (â‚©) | 7000 - 14140 | ||
Shares Outstanding (Mil) | 4.86 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bioinfra Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bioinfra Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Bioinfra Co Ltd Frequently Asked Questions
What is Bioinfra Co Ltd(XKRX:199730)'s stock price today?
When is next earnings date of Bioinfra Co Ltd(XKRX:199730)?
Does Bioinfra Co Ltd(XKRX:199730) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |